Switch theme
Sign up to access all valuation multiples
Observe Medical ASA through its subsidiaries develops medical technology products that benefit patients and healthcare professionals. It has developed the product Sippi which is an automatic and digital urine meter and the technology Sippcoat that prevents bacterial migration in closed collection systems.
2019
12
Last FY Revenue $1.8M
Last FY EBITDA -$3.3M
$10.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Observe Medical achieved revenue of $1.8M and an EBITDA of -$3.3M.
Observe Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Observe Medical valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $1.8M | XXX | XXX | XXX |
| Gross Profit | XXX | $0.3M | XXX | XXX | XXX |
| Gross Margin | XXX | 17% | XXX | XXX | XXX |
| EBITDA | XXX | -$3.3M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -183% | XXX | XXX | XXX |
| EBIT | XXX | -$4.2M | XXX | XXX | XXX |
| EBIT Margin | XXX | -231% | XXX | XXX | XXX |
| Net Profit | XXX | -$12.4M | XXX | XXX | XXX |
| Net Margin | XXX | -687% | XXX | XXX | XXX |
| Net Debt | XXX | $8.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Observe Medical's stock price is NOK 1 (or $0).
Observe Medical has current market cap of NOK 24.8M (or $2.4M), and EV of NOK 109M (or $10.7M).
See Observe Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $10.7M | $2.4M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Observe Medical has market cap of $2.4M and EV of $10.7M.
Observe Medical's trades at 5.9x EV/Revenue multiple, and -3.2x EV/EBITDA.
Equity research analysts estimate Observe Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Observe Medical's P/E ratio is not available.
See valuation multiples for Observe Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.4M | XXX | $2.4M | XXX | XXX | XXX |
| EV (current) | $10.7M | XXX | $10.7M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 5.9x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -3.2x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -2.5x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -0.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -3.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialObserve Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.4M for the same period.
Observe Medical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Observe Medical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Observe Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -183% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 248% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Observe Medical acquired XXX companies to date.
Last acquisition by Observe Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Observe Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Observe Medical founded? | Observe Medical was founded in 2019. |
| Where is Observe Medical headquartered? | Observe Medical is headquartered in Norway. |
| How many employees does Observe Medical have? | As of today, Observe Medical has 12 employees. |
| Is Observe Medical publicy listed? | Yes, Observe Medical is a public company listed on OSL. |
| What is the stock symbol of Observe Medical? | Observe Medical trades under OBSRV ticker. |
| When did Observe Medical go public? | Observe Medical went public in 2019. |
| Who are competitors of Observe Medical? | Similar companies to Observe Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Observe Medical? | Observe Medical's current market cap is $2.4M |
| Is Observe Medical profitable? | Yes, Observe Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
